This opportunity funds research projects that perform secondary analysis and integration of existing datasets to elucidate cancer risk and related outcomes such as risk prediction, survival, and treatment response. Applicants should leverage clinical, environmental, genomic, behavioral, and molecular data to address key scientific questions in cancer research through innovative or advanced analytical methods. Clinical trials are not allowed under this R01 mechanism.
Eligible applicants include various government entities, nonprofits, institutions of higher education, small businesses, for-profit organizations, and Native American tribal organizations. Specific eligibility details are provided in the full announcement.
